A Randomized Exploratory Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) for Cognitive Enhancement in Schizophrenia

Neuropsychopharmacology - United Kingdom
doi 10.1038/npp.2012.259
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Effects of an Alpha 7-Nicotinic Agonist on Default Network Activity in Schizophrenia

Biological Psychiatry
Biological Psychiatry
2011English

Cognitive Enhancement in Schizophrenia

Psychiatric Clinics of North America
PsychiatryMental Health
2012English

Cognitive Enhancement Therapy in Substance Misusing Schizophrenia: Results of an 18-Month Feasibility Trial

Schizophrenia Research
PsychiatryMental HealthBiological Psychiatry
2015English

Amyloid Β Precursor Protein (APP); Nicotinic Acetylcholine Receptor Alpha 7 (CHRNA7)

Science-Business eXchange
2009English

Cognitive–behavioural Therapy for Patients With Schizophrenia: A Multicentre Randomized Controlled Trial in Beijing, China

Psychological Medicine
PsychiatryMental HealthApplied Psychology
2014English

Acetylcholine and the Alpha 7 Nicotinic Receptor: A Potential Therapeutic Target for the Treatment of Periodontal Disease?

Inflammation Research
ImmunologyPharmacology
2012English

A Potential Role of Alpha-7 Nicotinic Acetylcholine Receptor in Cardiac Angiogenesis in a Pressure-Overload Rat Model

Journal of Pharmacological Sciences
Molecular MedicinePharmacology
2010English

Role of the Cytoplasmatic M3-M4 Loop for the Homopentameric Assembly of a Chimeric Nicotinic Alpha 7 Receptor

Biophysical Journal
Biophysics
2019English

Nicotinic Alpha 7 Receptor Expression and Modulation of the Lung Epithelial Response to Lipopolysaccharide

PLoS ONE
Multidisciplinary
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy